DPP4 and neoplasm: Adding sitagliptin to the four-armed experiment reduced DPP4 activity in the tumours (Fig. 4b), most likely by reducing the activity in non-tumour cells, as ID8-Trp53(−/−) cells showed no DPP4 activity in vitro (Fig. S3F).